These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 30135220)

  • 21. Aedes Aegypti saliva enhances chikungunya virus replication in human skin fibroblasts via inhibition of the type I interferon signaling pathway.
    Wichit S; Diop F; Hamel R; Talignani L; Ferraris P; Cornelie S; Liegeois F; Thomas F; Yssel H; Missé D
    Infect Genet Evol; 2017 Nov; 55():68-70. PubMed ID: 28866137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of Aedes aegypti populations in Madeira Island to transmit dengue and chikungunya viruses.
    Seixas G; Jupille H; Yen PS; Viveiros B; Failloux AB; Sousa CA
    Parasit Vectors; 2018 Sep; 11(1):509. PubMed ID: 30208974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tarsal exposure to atovaquone inhibits chikungunya virus transmission by Aedes aegypti mosquitoes, but not the transmission of Zika virus.
    Wang L; Sanon A; Khoiriyah Z; Verwimp S; Abdelnabi R; Delang L
    Antiviral Res; 2023 Sep; 217():105694. PubMed ID: 37532005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and Vector Competence Studies of Chikungunya Virus Lacking Repetitive Motifs in the 3' Untranslated Region of the Genome.
    Karliuk Y; Vom Hemdt A; Wieseler J; Pfeffer M; Kümmerer BM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33806267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chikungunya virus transmission potential by local Aedes mosquitoes in the Americas and Europe.
    Vega-Rúa A; Lourenço-de-Oliveira R; Mousson L; Vazeille M; Fuchs S; Yébakima A; Gustave J; Girod R; Dusfour I; Leparc-Goffart I; Vanlandingham DL; Huang YJ; Lounibos LP; Mohamed Ali S; Nougairede A; de Lamballerie X; Failloux AB
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003780. PubMed ID: 25993633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and genetic characterization of chikungunya virus from Aedes mosquito vector collected in the Lucknow district, North India.
    Nyari N; Maan HS; Sharma S; Pandey SN; Dhole TN
    Acta Trop; 2016 Jun; 158():117-124. PubMed ID: 26943997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of mosquito "quasispecies" in selecting an epidemic arthropod-borne virus.
    Vazeille M; Zouache K; Vega-Rúa A; Thiberge JM; Caro V; Yébakima A; Mousson L; Piorkowski G; Dauga C; Vaney MC; Manni M; Gasperi G; de Lamballerie X; Failloux AB
    Sci Rep; 2016 Jul; 6():29564. PubMed ID: 27383735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-D-N
    Rosales-Rosas AL; Soto A; Wang L; Mols R; Fontaine A; Sanon A; Augustijns P; Delang L
    Antiviral Res; 2024 May; 225():105858. PubMed ID: 38490342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes.
    Mishra P; Furey C; Balaraman V; Fraser MJ
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27294950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chikungunya Virus Infection of Aedes Mosquitoes.
    Wong HV; Chan YF; Sam IC; Sulaiman WY; Vythilingam I
    Methods Mol Biol; 2016; 1426():119-28. PubMed ID: 27233266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vector competence of Italian Aedes albopictus populations for the chikungunya virus (E1-226V).
    Severini F; Boccolini D; Fortuna C; Di Luca M; Toma L; Amendola A; Benedetti E; Minelli G; Romi R; Venturi G; Rezza G; Remoli ME
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006435. PubMed ID: 29672511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chikungunya virus transmission between Aedes albopictus and laboratory mice.
    Hugo LE; Prow NA; Tang B; Devine G; Suhrbier A
    Parasit Vectors; 2016 Oct; 9(1):555. PubMed ID: 27760560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chikungunya virus and its mosquito vectors.
    Higgs S; Vanlandingham D
    Vector Borne Zoonotic Dis; 2015 Apr; 15(4):231-40. PubMed ID: 25674945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Sudeep AB; Shil P
    J Vector Borne Dis; 2017; 54(4):295-300. PubMed ID: 29460858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for natural vertical transmission of chikungunya viruses in field populations of Aedes aegypti in Delhi and Haryana states in India-a preliminary report.
    Jain J; Kushwah RBS; Singh SS; Sharma A; Adak T; Singh OP; Bhatnagar RK; Subbarao SK; Sunil S
    Acta Trop; 2016 Oct; 162():46-55. PubMed ID: 27282096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
    Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
    J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.